Treatment of Operable Stage III–IV Lip Cancer Without Positive Margins or Extracapsular Spread

Advanced lip cancer at the commissure presenting at stages III or IV requires a coordinated multimodal approach. When the tumour is operable and pathology confirms no positive surgical margins and no extracapsular spread of nodal metastasis, a distinct treatment pathway applies.

Clinical Scenario

Lip cancer (commissure of lip), stage III or IV, judged operable — with confirmed absence of positive surgical margins and no extracapsular spread of nodal metastasis.

Treatment Approach — Partial Overview

Traditional management for this stage of lip cancer involves surgical resection of the tumour with neck dissection and reconstruction, followed by post-operative external beam radiotherapy. The complete protocol — including dosing targets, timing specifications, and the full eligibility criteria — is available via the link below.

Detailed sequencing, dose thresholds, and adjuvant considerations are in the full structured regimen.

Instant Access to Structured Evidence-Based Regimens

References

For advanced disease, stages III and IV (T3, T4 N0 and T1–4 N1), traditional management includes surgical resection, neck dissection, reconstruction and post-operative RT.

The latter should be offered to at least 60 Gy equivalent and optimally start within 6 weeks of surgery.

The primary aim of surgery in oral cavity cancer is tumour resection with a clinical clearance of ideally 1 cm (vital structures permitting).

In fit patients under the age of 71, adjuvant radiochemotherapy up to 66 Gy with concurrent platinum-based chemotherapy should be considered for those with positive surgical margins and/or ECS.

DOI: 10.1017/S0022215116000499

View source ↗